Literature DB >> 17074480

Design of a selective chemical probe for class I PDZ domains.

Naoaki Fujii1, Anang Shelat, Randy A Hall, R Kiplin Guy.   

Abstract

Covalent labeling has been widely used for structural and functional analyses of proteins. To target a wide range of PDZ domains, we designed a chemical scaffold mimicking the E/D-T/S-XV peptide, which is a PDZ domain that binds ligands in higher occurrence. A chemical probe (2) that contained this moiety alkylated diverse PDZ domains, including NHERF-1 PDZ2, and differentially visualized the cellular proteome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074480     DOI: 10.1016/j.bmcl.2006.10.027

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Therapeutic use of PDZ protein-protein interaction antagonism.

Authors:  Nick X Wang; Ho-Jin Lee; Jie J Zheng
Journal:  Drug News Perspect       Date:  2008-04

Review 2.  Emerging Themes in PDZ Domain Signaling: Structure, Function, and Inhibition.

Authors:  Xu Liu; Ernesto J Fuentes
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-28       Impact factor: 6.813

Review 3.  Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas.

Authors:  Weiqiang Zhang; Naoaki Fujii; Anjaparavanda P Naren
Journal:  Future Med Chem       Date:  2012-03       Impact factor: 3.808

4.  Functional regulation of cystic fibrosis transmembrane conductance regulator-containing macromolecular complexes: a small-molecule inhibitor approach.

Authors:  Weiqiang Zhang; Himabindu Penmatsa; Aixia Ren; Chandanamali Punchihewa; Andrew Lemoff; Bing Yan; Naoaki Fujii; Anjaparavanda P Naren
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

5.  An in silico analysis of the binding modes and binding affinities of small molecule modulators of PDZ-peptide interactions.

Authors:  Garima Tiwari; Debasisa Mohanty
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.